An observational study in ADHD, sponsored by Health Sciences North Research Institute. Terminated at 1 site in Canada. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-10-05.
Sponsored by Health Sciences North Research Institute · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 85 studies in Attention Deficit Disorder with Hyperactivity with a site in Canada — 12 open to participants now, 16 under way, none of them phase 3. Attention Deficit Disorder with Hyperactivity · Canada.
Among the 85 studies in Attention Deficit Disorder with Hyperactivity with a site in Canada, this one is the 13th largest by enrollment of the 13 observational ones that give a count, is one of 5 that started in 2018, is one of 13 observational ones, and was the 63rd registered.
1,821 studies on the registry are indexed under Attention Deficit Disorder with Hyperactivity; 297 are open to participants now.
Browse Attention Deficit Disorder with Hyperactivity studies →12 of the 85 studies in Attention Deficit Disorder with Hyperactivity with a site in Canada are open now. Recruiting first, the newest first:
Dar Clinical Research Inc. · Sites in Canada
Ages 65+
University of Calgary · Sites in Canada
Ages 9–15
University of Calgary · Sites in Canada
Ages 10+ · Women only · Healthy volunteers
Holland Bloorview Kids Rehabilitation Hospital · Sites in Canada
Ages 8–17
Douglas Mental Health University Institute · Sites in Canada
Ages 9–25 · Healthy volunteers
A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →
Of the 200 Attention Deficit Disorder with Hyperactivity studies recruiting now, 26 (13%) set no upper age limit and 169 (85%) stop at 75 or younger; 141 take children under 18; 55 take healthy volunteers.
This study: 18 Years to 60 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
85 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 5 · Phase 2 14 · Phase 3 18 · Phase 4 17
First in 1999; this study’s year is marked. 5 started in 2018.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 1 is below the median of 133 across 331 observational studies indexed under Attention Deficit Disorder with Hyperactivity.
Median enrollment 108 across the 72 interventional studies, 195 across the 13 observational. Of the 57 that completed or were terminated, 12 (21%) have results posted.
This tab as a report to print or save as PDF → With an account.
22 of 85 have an industry lead sponsor. The 10 most frequent:
Health Sciences North Research Institute is the lead sponsor of 10 studies on the registry; none are open to participants now.
Health Sciences North Research Institute has 1 study filed under Attention Deficit Disorder with Hyperactivity — fewer than ten, so there is no comparison to draw.
6 of the studies in Attention Deficit Disorder with Hyperactivity with a site in Canada that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04278404Duke UniversityPharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS) | 2026-11 |
| NCT07597707University of CalgaryInvestigating Health, Equity, and Resilience in Girls and Women With ADHD Across the Lifespan | 2026-12-31 |
| NCT05916339Daniel CouryAWARE: Management of ADHD in Autism Spectrum Disorder | 2027-01-01 |
| NCT07926776University of ManitobaSupporting Families of School-Aged Children With ADHD: A Dual-Generation Therapy Approach Through the BRIDGE Program | 2027-05-31 |
| NCT07710014Dar Clinical Research Inc.Evaluation of Foquest in Adults 65 Years and Older With ADHD | 2027-07-21 |
Add all 6 to your calendar (.ics) → With an account.
Among the 85 studies in Attention Deficit Disorder with Hyperactivity with a site in Canada, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The study is an investigation to determine co-morbid symptoms between adult major depressive disorder (MDD) and adult attention-deficit hyperactivity disorder (ADHD) using a novel statistical technique called network analysis.
We will gather a recruitment of 500 male and female outpatients from the Psychiatric Outpatient Clinic at Kirkwood Site attached to Health Sciences North.
Inclusion Criteria:
Co-morbidity
Characterize the ADHD/MDD symptom network in a psychiatric outpatient setting comprised of adults
Time frame: September 8, 2021
Network reliability
Determine the stability and reliability of this network
Time frame: September 8, 2021
Central symptoms
Determine the central symptoms that lead to co-activation of ADHD/MDD clusters
Time frame: September 8, 2021
Plan to share: No — None of the IPD will be shared with other researchers
No publications or documents are linked to this record.
Ran from Jun 2018 to primary completion in Dec 2023, 65 months.
How these figures are worked out, and which studies are left out of them.
This study is terminated, as verified in Aug 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Attention Deficit Disorder with Hyperactivity →
Health Sciences North Research Institute